Tenon Medical Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Tenon Medical şirketinin toplam hissedar öz sermayesi $832.0K ve toplam borcu $0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $6.0M ve $5.2M dir.

Anahtar bilgiler

Borç/özkaynak oranı

US$0

Borç

Faiz karşılama oranı	n/a
Nakit	US$1.97m
Eşitlik	US$832.00k
Toplam yükümlülükler	US$5.17m
Toplam varlıklar	US$6.01m

Son finansal sağlık güncellemeleri

Recent updates

We're A Little Worried About Tenon Medical's (NASDAQ:TNON) Cash Burn Rate

Nov 29

Is Tenon Medical (NASDAQ:TNON) In A Good Position To Invest In Growth?

Aug 15

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: TNON 'nin kısa vadeli varlıkları ( $4.1M ) kısa vadeli yükümlülüklerini ( $3.4M ) aşıyor.

Uzun Vadeli Yükümlülükler: TNON şirketinin kısa vadeli varlıkları ( $4.1M ) uzun vadeli yükümlülüklerini ( $1.8M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: TNON borçsuzdur.

Borcun Azaltılması: TNON un 5 yıl önce borcu yoktu.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: TNON son raporlanan serbest nakit akışına göre 2 ay boyunca yeterli nakit pistine sahiptir, ancak o zamandan beri ek sermaye artırmıştır.

Tahmini Nakit Akışı: TNON serbest nakit akışı tahminlerine göre 2 ay boyunca yeterli nakit akışına sahip olması öngörülüyor, ancak o zamandan beri ek sermaye artırdı.

Tenon Medical Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Tenon Medical Regains Full Compliance with Nasdaq Continued Listing Requirements

Tenon Medical Announces Update on Non-Compliance with the Minimum Stockholders’ Equity Requirement

Tenon Medical Receives Non-Compliance Letter Regarding Minimum Float Requirement

Tenon Medical Receives Notice from Nasdaq Regarding Non-Compliance with the Minimum Bid Price Requirement Pursuant to Nasdaq Listing Rule 5550(a)(2)

Tenon Medical Receives Non-Compliance Notice From Nasdaq

Tenon Medical Receives Non-Compliance Notice from Nasdaq Regarding Non-Compliance with Minimum Closing Bid Price

Recent updates

Tenon Medical, Inc. to Report Q3, 2024 Results on Nov 13, 2024

Tenon Medical Regains Full Compliance with Nasdaq Continued Listing Requirements

Tenon Medical Announces Update on Non-Compliance with the Minimum Stockholders’ Equity Requirement

Tenon Medical, Inc. has completed a Follow-on Equity Offering in the amount of $4.499971 million.

Consensus EPS estimates upgraded to US$19.35 loss

Tenon Medical, Inc. has filed a Follow-on Equity Offering in the amount of $4.500088 million.

Tenon Medical Receives Non-Compliance Letter Regarding Minimum Float Requirement

Tenon Medical, Inc. Appoints Kevin Williamson as Chief Financial Officer

Consensus EPS estimates upgraded to US$3.73 loss, revenue downgraded

Second quarter 2024 earnings: EPS exceeds analyst expectations

Tenon Medical, Inc. has filed a Follow-on Equity Offering in the amount of $6 million.

Tenon Medical, Inc. to Report Q2, 2024 Results on Aug 13, 2024

Tenon Medical, Inc., Annual General Meeting, Jul 23, 2024

Consensus EPS estimates fall by 18%, revenue upgraded

Consensus EPS estimates fall by 11%

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Tenon Medical Receives Notice from Nasdaq Regarding Non-Compliance with the Minimum Bid Price Requirement Pursuant to Nasdaq Listing Rule 5550(a)(2)

Tenon Medical, Inc. to Report Q1, 2024 Results on May 14, 2024

Tenon Medical, Inc. Appoints Kristine Jacques as Independent Member of the Board of Directors

Consensus revenue estimates decrease by 12%, EPS upgraded

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Tenon Medical, Inc. to Report Q4, 2023 Results on Mar 12, 2024

Tenon Medical Receives Non-Compliance Notice From Nasdaq

Tenon Medical, Inc. Announces Resignation of Frank Fischer as Member of Board of Directors, Audit Committee and Chairman of the Compensation Committee

New major risk - Financial position

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

New major risk - Revenue and earnings growth

Consensus revenue estimates decrease by 12%, EPS upgraded

Tenon Medical, Inc. to Report Q3, 2023 Results on Nov 14, 2023

Tenon Medical(R) Announces First Patients Treated with New Jib Instrument Kit for Catamaran(R) Si Joint Fusion System

Tenon Medical, Inc. announced that it has received $0.286835 million in funding from Lincoln Park Capital, LLC

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Tenon Medical, Inc., Annual General Meeting, Sep 13, 2023

Tenon Medical, Inc. to Report Q2, 2023 Results on Aug 08, 2023

Tenon Medical Receives Non-Compliance Notice from Nasdaq Regarding Non-Compliance with Minimum Closing Bid Price

New major risk - Shareholder dilution

Tenon Medical, Inc. has completed a Composite Units Offering in the amount of $5.6 million.

New major risk - Share price stability

New major risk - Market cap size

Founder recently sold US$82k worth of stock

Tenon Medical Receives A Written Notice from Nasdaq Regarding Minimum Stockholders' Equity Requirement for Continued Listing on the Nasdaq Capital Market

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Full year 2022 earnings released

We're A Little Worried About Tenon Medical's (NASDAQ:TNON) Cash Burn Rate

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Third quarter 2022 earnings released

Tenon Medical, Inc. to Report Q3, 2022 Results on Nov 10, 2022

Tenon Medical, Inc.'s Catamaran SI Joint Fusion System Receives Institutional Review Board Approval for Two Strategic Post Market Studies

Is Tenon Medical (NASDAQ:TNON) In A Good Position To Invest In Growth?

Second quarter 2022 earnings released: US$0.65 loss per share (vs US$2.01 loss in 2Q 2021)

Tenon Medical, Inc. to Report Q2, 2022 Results on Aug 11, 2022

First quarter 2022 earnings released: US$2.38 loss per share (vs US$0.24 loss in 1Q 2021)

High number of new directors

Tenon Medical, Inc. has completed an IPO in the amount of $16 million.

Less than half of directors are independent

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin